Evidence map›Paper›PMID 37579750›Full record

ArticleBiofabrication2023

Sacrificial scaffold-assisted direct ink writing of engineered aortic valve prostheses.

Cheng Zhang, Jiangtao Hao, Weiliang Shi, Ya Su, Kellen Mitchell, Weijian Hua, Wenbo Jin, Serena Lee, Lai Wen, Yifei Jin and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Biofabrication, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Multiscale embedded printing of engineered human tissue and organ equivalents.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Cheng ZhangState Key Laboratory of High-performance Precision Manufacturing, Dalian University of Technology, Dalian, Liaoning, People's Republic of China.
Jiangtao HaoState Key Laboratory of High-performance Precision Manufacturing, Dalian University of Technology, Dalian, Liaoning, People's Republic of China.
Weiliang ShiState Key Laboratory of High-performance Precision Manufacturing, Dalian University of Technology, Dalian, Liaoning, People's Republic of China.
Ya SuSchool of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning, People's Republic of China.
Kellen MitchellDepartment of Mechanical Engineering, University of Nevada, Reno, Reno, NV, United States of America.
Weijian HuaDepartment of Mechanical Engineering, University of Nevada, Reno, Reno, NV, United States of America.
Wenbo JinState Key Laboratory of High-performance Precision Manufacturing, Dalian University of Technology, Dalian, Liaoning, People's Republic of China.
Serena LeeDepartment of Pharmacology, Center for Molecular and Cellular Signaling in the Cardiovascular System, School of Medicine, University of Nevada, Reno, Reno, NV, United States of America.
Lai WenDepartment of Pharmacology, Center for Molecular and Cellular Signaling in the Cardiovascular System, School of Medicine, University of Nevada, Reno, Reno, NV, United States of America.
Yifei JinDepartment of Mechanical Engineering, University of Nevada, Reno, Reno, NV, United States of America.ORCID 0000-0003-4336-1802
Danyang ZhaoState Key Laboratory of High-performance Precision Manufacturing, Dalian University of Technology, Dalian, Liaoning, People's Republic of China.
University of Nevada, Reno · USDalian University of Technology · CN

Funding

Transgenic Animal Genotyping and Phenotyping CoreP20GM130459 · NIGMS · UNIVERSITY OF NEVADA RENO · PI Andreia Nunes · 2019 to 2026
$20.3M
NIGMS NIH HHS P20 GM130459
6 · The paper itself

Abstract

Heart valve disease has become a serious global health problem, which calls for numerous implantable prosthetic valves to fulfill the broader needs of patients. Although current three-dimensional (3D) bioprinting approaches can be used to manufacture customized valve prostheses, they still have some complications, such as limited biocompatibility, constrained structural complexity, and difficulty to make heterogeneous constructs, to name a few. To overcome these challenges, a sacrificial scaffold-assisted direct ink writing approach has been explored and proposed in this work, in which a sacrificial scaffold is printed to temporarily support sinus wall and overhanging leaflets of an aortic valve prosthesis that can be removed easily and mildly without causing any potential damages to the valve prosthesis. The bioinks, composed of alginate, gelatin, and nanoclay, used to print heterogenous valve prostheses have been designed in terms of rheological/mechanical properties and filament formability. The sacrificial ink made from Pluronic F127 has been developed by evaluating rheological behavior and gel temperature. After investigating the effects of operating conditions, complex 3D structures and homogenous/heterogenous aortic valve prostheses have been successfully printed. Lastly, numerical simulation and cycling experiments have been performed to validate the function of the printed valve prostheses as one-way valves.

Indexed as

BioprintingInkAortic ValveHumansHydrogelsPrinting, Three-DimensionalTissue EngineeringTissue ScaffoldsHydrogels3D bioprintingaortic valve prosthesisbioink characterizationdirect ink writingsacrificial scaffold

Identifiers

PMID37579750
PMCPMC10566457
OpenAlexW4385799783

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.